English

More about this topic

Health news

Using food delivery apps linked to obesity risk and lower-level jobs

Could how you purchase food online be linked to your social position and likelihood of obesity? New research from the UK suggests it might be.

Health news

Sugary drink intake up 23% globally since 1990, study finds

Global intake of sugar-sweetened beverages has risen alongside child obesity in recent decades, with the highest consumption levels in Latin America and the Middle East and North Africa.

Business

Investors look to weight loss drugs to boost Novo Nordisk growth

Novo Nordisk is releasing its second-quarter earnings on Wednesday, with analysts expecting more than 20% growth driven by Ozempic and Wegovy sales. However, the company faces challenges from more competition.

Health news

Weight loss drug may cut heart failure risk, company says

New results from a clinical trial evaluating the drug showed positive results for reducing heart failure risk.

ADVERTISEMENT

Business

Roche plans speedy weight-loss drug launch to catch up with rivals

Roche believes its anti-obesity drugs could have advantages over other more established rivals such as Eli Lilly and Novo Nordisk through ease of scalability that will allow it to meet increased demand.

Health news

UK sugar tax slashed children's added sugar intake by half

Many soft drink manufacturers reformulated their products after the tax was announced in 2016, helping to reduce kids’ added sugar consumption over the next three years.

Business

Wegovy and Ozempic maker Novo Nordisk plans billion-dollar US plant

Novo Nordisk announces a plan to invest $4.1 billion to expand its capacity of making weight loss drug Wegovy and diabetes treatment Ozempic.

Health news

Popular obesity drug may help treat sleep apnoea

The drug tirzepatide is marketed as Mounjaro and Zepbound by pharmaceutical company Eli Lilly and belongs to the same class of drugs as semaglutide.

Health news

Global health authorities issue warning about fake Ozempic

A new global warning was issued over falsified versions of a popular weight-loss and type 2 diabetes drug.

Health news

Girls are experiencing earlier and more irregular periods, study says

A recent study found that girls are starting menstruation earlier and experiencing more irregular cycles, which could be influenced by factors like obesity and environmental chemicals.

Health news

Prenatal exposure to chemicals may increase risk of childhood obesity

Exposure to endocrine-disrupting chemicals during pregnancy may increase the risk of obesity and hypertension in children, new research suggests.

Health news

'Ozempic breasts': What are the side effects of weight loss drugs?

While many people suffering from obesity have been using Ozempic to help with weight loss, health professionals are warning of potential side effects.

wellbeing

COVID linked to less activity, more screen time among children

A new report from WHO said that the COVID-19 pandemic led to more screen time and less physical activity among European children.

Health news

Ozempic found to cut heart disease and keep weight off for four years

New analyses of a large trial presented at the European Congress on Obesity showed the clear benefits of the popular weight-loss drug.

Health news

What is the sugar scandal hitting Nestlé and what happens now?

A new investigation found that one portion of Nestlé cereal for six-months-old babies contained around a cube and a half of sugar per serving.

Health news

More people worldwide are suffering from neurological issues than ever

Researchers warn the cost to health systems around the world will be severe if more is not done to prevent and treat these diseases.

Business

How much higher can Novo Nordisk shares go?

Novo Nordisk's remarkable ascent, driven by its revolutionary weight-loss drug Wegovy, has led to a surge in market value and positive analyst outlook.

Business

Novo Nordisk expands lead on Tesla on upbeat obesity drug trial

Novo Nordisk, of anti-obesity drug Wegovy fame, reveals encouraging initial trial data for new weight loss drug that could potentially overtake Wegovy.

Health news

More than one billion people globally are obese, study finds

Obesity rates have increased dramatically among children, teenagers, and adults, with more than one billion people in the world now affected.

Health news

Ozempic, Wegovy not linked to increased risk of suicidal thoughts

The researchers called for closer evaluation of reports of suicidal thoughts linked to the diabetes and obesity drugs and for patients to be followed for a longer period of time.